Morgan Stanley maintains Overweight rating on CME Group
Morgan Stanley maintained an Overweight rating on CME Group, per Benzinga ratings actions.
Story updates
12:39:09 PM UTC
SquawkNews
CME Group Price Target Raised to $337.00/Share From $330.00 by Morgan Stanley